Cargando…
A Noninvasive Tool Based on Magnetic Resonance Imaging Radiomics for the Preoperative Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
PURPOSE: This study aimed to identify patients with pathological complete response (pCR) and make better clinical decisions by constructing a preoperative predictive model based on tumoral and peritumoral volumes of multiparametric magnetic resonance imaging (MRI) obtained before neoadjuvant chemoth...
Autores principales: | Li, Chenchen, Lu, Nian, He, Zifan, Tan, Yujie, Liu, Yajing, Chen, Yongjian, Wu, Zhuo, Liu, Jingwen, Ren, Wei, Mao, Luhui, Yu, Yunfang, Xie, Chuanmiao, Yao, Herui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550709/ https://www.ncbi.nlm.nih.gov/pubmed/35773561 http://dx.doi.org/10.1245/s10434-022-12034-w |
Ejemplares similares
-
Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study
por: Yu, Yunfang, et al.
Publicado: (2021) -
Machine learning radiomics of magnetic resonance imaging predicts recurrence-free survival after surgery and correlation of LncRNAs in patients with breast cancer: a multicenter cohort study
por: Yu, Yunfang, et al.
Publicado: (2023) -
CT Radiomics for Predicting Pathological Complete Response of Axillary Lymph Nodes in Breast Cancer After Neoadjuvant Chemotherapy: A Prospective Study
por: Li, Yan-Ling, et al.
Publicado: (2023) -
Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics–Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer
por: Yu, Yunfang, et al.
Publicado: (2020) -
Magnetic resonance imaging radiomics signatures for predicting endocrine resistance in hormone receptor-positive non-metastatic breast cancer
por: Yang, Yaping, et al.
Publicado: (2021)